Joseph I Boullata Selected Research

teduglutide

8/2018	Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
1/2017	Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
11/2016	Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
1/2016	A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide.
3/2013	Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph I Boullata Research Topics

Disease

5	Critical Illness (Critically Ill) 02/2022 - 01/2013
5	Short Bowel Syndrome 08/2018 - 03/2013
5	Intestinal Failure 08/2018 - 03/2013
2	Body Weight (Weight, Body) 01/2022 - 11/2010
2	Thrombosis (Thrombus) 01/2016 - 03/2014
2	Morbid Obesity 03/2014 - 02/2008
2	Weight Loss (Weight Reduction) 03/2013 - 06/2003
2	Obesity 11/2010 - 02/2008
2	Malnutrition (Nutritional Deficiencies) 11/2010 - 06/2010
1	Inflammation (Inflammations) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Exocrine Pancreatic Insufficiency 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Confusion (Bewilderment) 01/2018
1	Disease Progression 11/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Cancer Pain 02/2015
1	Infections 03/2014
1	Diarrhea 03/2013
1	Protein-Energy Malnutrition (Marasmus) 11/2010
1	Osteoporosis 02/2008
1	Secondary Hyperparathyroidism 02/2008
1	Bone Diseases (Bone Disease) 02/2008
1	Hypersensitivity (Allergy) 06/2003
1	Anaphylaxis (Anaphylactic Shock) 06/2003

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 02/2021 - 06/2003
5	teduglutideIBA 08/2018 - 03/2013
2	LipidsIBA 01/2020 - 01/2018
2	EmulsionsIBA 01/2020 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Fish OilsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	25-hydroxyvitamin DIBA 01/2019
1	Glucagon-Like Peptide 2IBA 01/2016
1	Opioid Analgesics (Opioids)IBA 02/2015
1	BenzodiazepinesIBA 02/2015
1	Heparin (Liquaemin)FDA LinkGeneric 03/2014
1	Linezolid (Zyvox)FDA Link 03/2014
1	Trace Elements (Biometals)IBA 01/2013
1	CalciumIBA 02/2008
1	Vitamin D FDA LinkGeneric 02/2008
1	Diphenhydramine (Benadryl)FDA LinkGeneric 06/2003
1	SalicylatesIBA 06/2003
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2003
1	Methylprednisolone FDA LinkGeneric 06/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2003
1	willow bark extractIBA 06/2003

Therapy/Procedure

7	Parenteral Nutrition 01/2020 - 03/2013
2	Enteral Nutrition (Feeding, Tube) 02/2021 - 01/2019
2	Therapeutics 01/2020 - 11/2016
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 06/2010 - 02/2008
1	Critical Care (Surgical Intensive Care) 02/2022
1	Continuous Renal Replacement Therapy 01/2020
1	Injections 01/2018
1	Drug Therapy (Chemotherapy) 11/2016
1	Catheters 03/2014
1	Operative Surgical Procedures 02/2008
1	Resuscitation 06/2003